Change of Airway Hyperresponsiveness to Mannitol and Methacholine in Patients With Asthma
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
Control of airway inflammation is the cornerstone of asthma management. The aim of the
present pilot study was to assess whether, and in which magnitude, a leukotriene receptor
antagonist (LTRA) added to a basic treatment of inhaled corticosteroids (ICS) + long-acting
betamimetics (LABA) might improve airway hyperresponsiveness and inflammation in
well-controlled patients with asthma.
Phase:
Phase 4
Details
Lead Sponsor:
Cantonal Hosptal, Baselland University Hospital, Basel, Switzerland